Govt cancels licences of 18 pharma companies for producing spurious drugs
26 firms have been issued show-cause notices
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Ingredion announces strategic investments to expand into high-value pharma ingredients
As a result of these strategic investments, the company’s portfolio of functional excipients now includes binders, fillers,…
Indian Immunologicals gets regulatory approval for measles-rubella (MR) vaccine
This is the outcome of Indo-Vietnam partnership, where in Indian Immunologicals partnered with Center for Research and Production…
Vantage Nutrition acquires ComboCap
Vantage Nutrition is the only company in the world supplying Sidebyside health products to nutritional and pharmaceutical markets,…
Sanofi gets marketing approval for its diabetes drug Soliqua in India
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Lupin gets tentative US FDA approval for Valbenazine capsules
Valbenazine is indicated for the treatment of tardive dyskinesia (uncontrollable movement of face, tongue, or other body parts)
Panbela announces issuance of key patent in Japan
The patent, developed in collaboration with Syngene International, is for claims of a novel process for the production of SBP-101
Quantumzyme gets patent for development of green catalyst in India
The QZyme Workbench technology can handle a wide range of aspects of protein modeling and engineering, including structural…
Dr Reddy’s focuses on differentiated portfolio in key therapy areas for growth in India: GlobalData
DRL has earlier this month divested nine dermatology brands to Eris Lifesciences for Rs 2750 million ($33.3 million*). Within a…
GELITA launches fast-setting gelatin for fortified gummy production
Branded CONFIXX, the new gelatin allows starch-free production of gummies with a sensorial profile
Glenmark gets ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%|0.064%
With this approval, Glenmark is eligible for 180-days of generic drug exclusivity for Calcipotriene and Betamethasone Dipropionate…
Zydus gets Orphan Drug Designation from USFDA for ZYIL1 to treat Cryopyrin Associated Periodic…
Orphan drug designation by USFDA for ZYIL1 provides eligibility for certain development incentives, including tax credits for…
SII likely front-runner to win supply of HPV vaccines for Universal Immunisation Program: GlobalData
Currently, the Serum Institute of India is the only domestic player that was able to launch its homegrown HPV vaccine, 'Cervavac',…
Glenmark gets USFDA approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg
Glenmark’s current portfolio consists of 182 products authorised for distribution in the US marketplace
Bangalore, Delhi-NCR, Hyderabad are most preferred destinations for life sciences companies
According to the report, total leasing activity in 2022 by LS firms stood at 2.4 million sq. ft. and maintained the 2021 leasing…
AGI Greenpac gets CCI approval to acquire Hindustan National Glass & Industries
The acquisition will be done through the corporate insolvency resolution process
Eiko LifeSciences signs MoU with Vivacious Pharmatex
ELL to make strategic investment in VPPL by way of acquiring 5 per cent equity stake in VPPL
Unichem gets USFDA approval for ranolazine ER tablets, 500 mg and 1000 mg
Ranolazine ER tablets are indicated for the treatment of chronic angina
Jubilant gets additional loan from Canada Govt for expansion of CMO Montreal facility
Government of Canada to provide, through its Strategic Innovation Fund (SIF) program, a partially repayable loan of CAD 23.8…
US FDA accepts Glenmark’s IND application for GRC 54276 to proceed with Phase 1/2 clinical study for…
GRC54276 is an orally available, small molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor developed by Glenmark